+43,351.9%
SBUX vs GSK
+742.1%
+42,609.9%
-81.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.2% | +0.5% | -0.7% | -0.4% |
| 7D | +1.6% | +1.1% | +0.4% | +1.2% |
| 30D | +14.8% | +6.3% | +8.5% | +12.5% |
| 3M | -0.8% | +1.8% | -2.6% | -1.6% |
| 6M | +2.2% | +1.7% | +0.6% | +1.2% |
| YTD | +29.5% | +6.5% | +22.9% | +25.4% |
| 1Y | +27.0% | +9.5% | +17.5% | +21.9% |
| 3Y | +10.9% | +65.3% | -54.4% | -10.2% |
| 5Y | +7.4% | +43.7% | -36.3% | -10.2% |
| 10Y | +146.3% | +104.1% | +42.2% | +80.0% |
| All | +43,351.9% | +742.1% | +42,609.9% | +22,312.7% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling